United States · Platforms & data · The Motley Fool

Bristol Myers Squibb vs. Novo Nordisk: Stable Scale vs. GLP-1 Volatility

Published by The Motley Fool · United States 1 h ago

Bristol Myers Squibb has led in seven of eight quarters, but Novo Nordisk's recent spike signals a shift worth watching for income-focused investors.

Read the full article on The Motley Fool Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.fool.com)

Also worth reading

Magna International (TSE:MG) Rating Lowered to "Hold" at Canadian Imperial Bank of Commerce

Mideast oil exports are recovering. Fresh attacks in Saudi Arabia show risks remain.

At a glance: stocks gapping down premarket

Best Tech Stocks Right Now

Barclays to slash 5,000 jobs in AI-powered cost-cutting drive

Bitcoin and ethereum prices today, Thursday, October 22, 2026: Crypto gains wiped out as oil prices stay over $111 a barrel